Jura CapitalMuhdo Health

Private Investor Webinar

The next layer of precision health

Muhdo Health combines genetics, epigenetics and AI to measure health at a cellular level, then sells that capability to clinics, laboratories and healthcare partners. Its management team joins Jura Capital to explain how the model works and where it is going.

Date
Wednesday 2 September 2026
Time
1:30PM BST
Format
Online, approx. 60 minutes
See the agenda
Nathan Berkley

Nathan Berkley

Chief Executive Officer, Muhdo Health

Richard Layton

Richard Layton

Chief Financial Officer, Muhdo Health

Why this matters

Health data is becoming dynamic

A DNA test is taken once. Epigenetic measurement can be repeated, which turns a single transaction into a longitudinal relationship and a growing dataset.

  1. 01

    Genetic baseline

    A single saliva sample establishes the starting point.

  2. 02

    Epigenetic measurement

    Biological change is measured, not just inherited risk.

  3. 03

    Personalised intervention

    Findings translate into specific, actionable changes.

  4. 04

    Retesting

    The same markers are measured again over time.

  5. 05

    Longitudinal data

    Each cycle deepens the dataset behind the platform.

About Muhdo

Built, validated and commercially active

Founded in 2017, Muhdo is a UK precision health technology company. Its proposition spans DNA and epigenetic testing, healthcare partnerships, AI assisted interpretation, white label products and portals, and API integration.

2017

Founded

An active UK precision health technology company, not a concept.

70,000+

Health profiles

Real world genetic and health data supporting MAISIE, Muhdo's AI health assistant.

B2B

Distribution

Clinics, laboratories, white label portals and API integration, each reaching many end users.

The session

What the webinar will cover

  • 01Why health data is moving from static to dynamic
  • 02How genetic and epigenetic measurement works in practice
  • 03The Muhdo platform, MAISIE and the clinician view
  • 04Commercial progress and the B2B distribution model
  • 05International expansion and licensing
  • 06Live questions with Nathan and Richard

Speakers

Hosted by Muhdo's management team

Nathan Berkley

Nathan Berkley

Chief Executive Officer, Muhdo Health

Richard Layton

Richard Layton

Chief Financial Officer, Muhdo Health

In conversation with the Jura Capital team.

Registration

Reserve your place

Places are limited and the session is not recorded for public release. Register below and we will send the calendar invitation straight away, followed by the joining link before the webinar.

Wednesday 2 September 2026, 1:30PM BST. Approximately 60 minutes, online.

Capital at risk. This webinar is for information only and is not investment, legal or tax advice.